Equitable Holdings’s Agios Pharmaceuticals AGIO Stock Holding History

Equitable Holdings’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-7,000	Closed	-$323K	–	854
2021 Q3	$323K	Sell	7,000 -1,000	-13%	-$48.3K	0.01%	651
2021 Q2	$441K	Hold	8,000	–	–	0.01%	564
2021 Q1	$413K	Buy	8,000 +1,000	+14%	+$49.5K	0.01%	549
2020 Q4	$303K	Hold	7,000	–	–	0.01%	556
2020 Q3	$245K	Sell	7,000 -16,000	-70%	-$701K	0.01%	553
2020 Q2	$1.23M	Buy	23,000 +2,000	+10%	+$92.6K	0.04%	275
2020 Q1	$745K	Sell	21,000 -3,000	-13%	-$139K	0.03%	306
2019 Q4	$1.15M	Buy	+24,000	New	+$907K	0.03%	274

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Equitable Holdings's AGIO Position: Q4 2021 in Review

Equitable Holdings sold out of Agios Pharmaceuticals (AGIO) in Q4 2021, closing a stake of 7,000 shares — an estimated $323K sold.

Equitable Holdings first reported a position in AGIO in Q4 2019 and held it in 8 quarters. The position peaked at $1.23M in Q2 2020. 160 funds tracked by Wall St. Rank hold AGIO as of Q4 2021.

Equitable Holdings reported no remaining Agios Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Equitable Holdings sold 7,000 Agios Pharmaceuticals shares in Q4 2021, an estimated $323K.
Equitable Holdings first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 8 quarters.
Equitable Holdings's Agios Pharmaceuticals position peaked at $1.23M in Q2 2020.
160 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2021.

Based on Equitable Holdings's 13F filing for Q4 2021, filed 11 Feb 2022.